Jingfeng Zong
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies 49
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 12
- Oncology top 5%
- Viral-associated cancers and disorders 12
- Lung Cancer Research Studies 8
- Surgery top 10%
- Head and Neck Surgical Oncology 21
-
- Lung Cancer Treatments and Mutations 11
- Lung Cancer Diagnosis and Treatment 8
-
- RNA modifications and cancer 9
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Jingfeng Zong
64 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 73
- Otorhinolaryngology 716
- Cancer Research 377
- Oncology 566
- Surgery 476
- Pulmonary and Respiratory Medicine 285
Countries citing papers authored by Jingfeng Zong
This map shows the geographic impact of Jingfeng Zong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingfeng Zong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingfeng Zong more than expected).
Fields of papers citing papers by Jingfeng Zong
This network shows the impact of papers produced by Jingfeng Zong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingfeng Zong. The network helps show where Jingfeng Zong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingfeng Zong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 13 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 3 | |
| 6 | 2021 | 5 | |
| 7 | 2020 | 10 | |
| 8 | 2019 | 2 | |
| 9 | 2019 | 8 | |
| 10 | 2019 | 1 | |
| 11 | 2019 | 45 | |
| 12 | 2018 | 9 | |
| 13 | 2018 | 72 | |
| 14 | 2015 | 5 | |
| 15 | 2015 | 3 | |
| 16 | 2015 | 31 | |
| 17 | 2013 | 1 | |
| 18 | 2013 | 1 | |
| 19 | A Retrospective Concurrent Control Study of Induction Chemotherapy in 104 Patients with Stage II Nasopharyngeal Carcinoma | 2012 | 1 |
| 20 | A prospective randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma | 2008 | 1 |
About Jingfeng Zong
Jingfeng Zong is a scholar working on Otorhinolaryngology, Oncology and Cancer Research, having authored 67 papers that have together received 1.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (49 papers), Head and Neck Surgical Oncology (21 papers), Viral-associated cancers and disorders (12 papers), Cancer-related molecular mechanisms research (12 papers), Lung Cancer Treatments and Mutations (11 papers), RNA modifications and cancer (9 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Otorhinolaryngology (716 citations), Cancer Research (377 citations) and Oncology (566 citations). Jingfeng Zong has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jianji Pan, Qiaojuan Guo, Shaojun Lin, Honglin Chen, Tianzhu Lu, Yixin Chen, Yuanji Xu, Youping Xiao, Shaojun Lin and Jiade J. Lu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.